3,4-dihydroxyphenylacetic acid has been researched along with neuropeptide y in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 14 (66.67) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daszuta, A; Moukhles, H; Nieoullon, A | 1 |
| Bloc, A; Dusticier, N; Forni, C; Kerkerian-Le Goff, L; Nieoullon, A; Samuel, D | 1 |
| Bratholm, P; Christensen, NJ; Eldrup, E; Hetland, ML | 1 |
| Alling, C; Heilig, M; Vècséi, L; Wahlestedt, C; Widerlöv, E | 1 |
| Beal, MF; Ellison, DW; Frank, RC; Martin, JB | 1 |
| Bray, GA; Shimizu, H | 1 |
| Bosler, O; Kerkerian, L; Nieoullon, A; Pelletier, G | 1 |
| Hastings, JA; Morris, MJ; Pavia, JM | 2 |
| Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P | 1 |
| Bouali, SM; Drumheller, A; Fournier, A; Jolicoeur, FB; St-Pierre, S | 1 |
| Beal, MF; Brouillet, E; Ferrante, RJ; Hyman, BT; Jenkins, BG; Kowall, NW; Miller, JM; Rosen, BR; Srivastava, R; Storey, E | 1 |
| Braas, KM; Brandenburg, CA; May, V | 1 |
| Guss, V; Korpinen, C; Matos, FF | 1 |
| Harris, RB; Ryan, DH; Rybkin, II; Smagin, GN; Volaufova, J; Zhou, Y | 1 |
| Hastings, JA; McClure-Sharp, JM; Morris, MJ | 1 |
| Buhot, MC; Compan, V; Daszuta, A; Segu, L | 1 |
| Adrian, TE; Arnelo, U; Ding, X; Herrington, MK; Larsson, J; Marcusson, J; Permert, J; Reidelberger, R; Strömmer, L; Theodorsson, E | 1 |
| Cheng, SM; Hsueh, YC; Pan, JT | 1 |
| Antkiewicz-Michaluk, L; Herman, ZS; Obuchowicz, E; Romańska, I | 1 |
| Brunetti, L; Chiavaroli, A; Di Nisio, C; Ferrante, C; Leone, S; Orlando, G; Recinella, L; Salvatori, R; Shohreh, R; Vacca, M | 1 |
21 other study(ies) available for 3,4-dihydroxyphenylacetic acid and neuropeptide y
| Article | Year |
|---|---|
Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain Tissue Transplantation; Corpus Striatum; Dextroamphetamine; Dopamine; Female; Fetal Tissue Transplantation; Immunohistochemistry; Mesencephalon; Neuropeptide Y; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 1992 |
Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Biological Transport; Cerebral Ventricles; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Glutamates; Injections, Intraventricular; Kinetics; Motor Activity; Neuropeptide Y; Rats; Rats, Inbred Strains; Reference Values | 1992 |
The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Norepinephrine; Supination; Sympathetic Nervous System | 1991 |
Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Male; Neuropeptide Y; Norepinephrine; Peptide Fragments; Phenylacetates; Rats; Rats, Inbred Strains | 1990 |
The effect of neuropeptide Y on striatal catecholamines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neuropeptide Y; Peptide YY; Peptides; Rats; Rats, Inbred Strains; Serotonin; Somatostatin | 1986 |
Effects of neuropeptide Y on norepinephrine and serotonin metabolism in rat hypothalamus in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Neuropeptide Y; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin | 1989 |
Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Histocytochemistry; Immunochemistry; Nerve Tissue Proteins; Neural Pathways; Neurons; Neuropeptide Y; Rats; Rats, Inbred Strains; Substantia Nigra; Tyrosine 3-Monooxygenase | 1986 |
Neuropeptide Y potentiation of potassium-induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Basal Metabolism; Drug Synergism; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Neuropeptide Y; Norepinephrine; Paraventricular Hypothalamic Nucleus; Potassium; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1995 |
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Injections, Intraperitoneal; Lactates; Magnetic Resonance Imaging; Male; Microinjections; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neuropeptides; Neurotoxins; Oxidative Phosphorylation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sodium Azide; Somatostatin; Substance P | 1994 |
Neurochemical effects of neuropeptide Y (NPY) and NPY2-36.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Neuropeptide Y; Norepinephrine; Peptide Fragments; Rats; Serotonin; Tissue Distribution | 1994 |
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calbindins; Cell Adhesion Molecules, Neuronal; Corpus Striatum; Dopamine; Energy Metabolism; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interneurons; Male; Mitochondria; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neurotoxins; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Reference Values; S100 Calcium Binding Protein G; Somatostatin; Substance P | 1993 |
Differential regulation of sympathetic neuron neuropeptide Y and catecholamine content and secretion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Bucladesine; Calcimycin; Catecholamines; Cells, Cultured; Colforsin; Dopamine; Electrochemistry; Female; Homeostasis; Homovanillic Acid; Immunohistochemistry; Kinetics; Neurons; Neuropeptide Y; Potassium; Pregnancy; Rats; Rats, Sprague-Dawley; Signal Transduction; Superior Cervical Ganglion; Tetradecanoylphorbol Acetate; Time Factors | 1995 |
Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Biogenic Monoamines; Dopamine; Feeding Behavior; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Microdialysis; Neuropeptide Y; Norepinephrine; Rats; Rats, Wistar; Serotonin | 1996 |
Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cerebral Ventricles; Drug Synergism; Homovanillic Acid; Injections, Intraventricular; Male; Microdialysis; Neuropeptide Y; Norepinephrine; Paraventricular Hypothalamic Nucleus; Potassium; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Effect of restraint stress on food intake and body weight is determined by time of day.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adipose Tissue; Animals; Biogenic Monoamines; Body Weight; Brain Stem; Circadian Rhythm; Darkness; Dopamine; Energy Metabolism; Epididymis; Feeding Behavior; Hypothalamus; Leptin; Light; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Norepinephrine; Paraventricular Hypothalamic Nucleus; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Reference Values; Restraint, Physical; RNA, Messenger; Serotonin; Stress, Psychological; Transcription, Genetic | 1997 |
In vitro studies of endogenous noradrenaline and NPY overflow from the rat hypothalamus during maturation and ageing.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Calcium; Chromatography, High Pressure Liquid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Neuropeptide Y; Norepinephrine; Potassium; Rats; Rats, Sprague-Dawley | 1998 |
Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A, 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Binding, Competitive; Cerebral Cortex; Dipeptides; Dopamine; Female; Fenclonine; Iodine Radioisotopes; Neuronal Plasticity; Neuropeptide Y; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Agents; Tritium | 1998 |
Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amyloid; Animals; Anorexia; Biogenic Monoamines; Blood Glucose; Brain; Cholecystokinin; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Infusions, Parenteral; Insulin; Islet Amyloid Polypeptide; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Neuropeptides; Neurotensin; Norepinephrine; Rats; Rats, Wistar; Serotonin | 2000 |
Fasting stimulates tuberoinfundibular dopaminergic neuronal activity and inhibits prolactin secretion in oestrogen-primed ovariectomized rats: involvement of orexin A and neuropeptide Y.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Proteins; Dopamine; Estrogens; Fasting; Female; Intracellular Signaling Peptides and Proteins; Median Eminence; Neurons; Neuropeptide Y; Neuropeptides; Orexin Receptors; Orexins; Ovariectomy; Pituitary Gland, Posterior; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Neuropeptide Y | 2002 |
Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Dopamine; Homovanillic Acid; Immunohistochemistry; Levodopa; Male; Mice; MPTP Poisoning; Neuropeptide Y; Neuroprotective Agents; Selegiline; Serotonin | 2003 |
Effects of growth hormone-releasing hormone gene targeted ablation on ghrelin-induced feeding.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alleles; Animals; Chromatography, High Pressure Liquid; Eating; Female; Genotype; Ghrelin; Growth Hormone; Growth Hormone-Releasing Hormone; Homovanillic Acid; Homozygote; Hydroxyindoleacetic Acid; Hypothalamus; Male; Mice; Mice, Knockout; Neuropeptide Y | 2017 |